tirzepatide microdosing for inflammation Compounded Microdose Exploring Microdosing GLP-1 Medications: Benefits

Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphological spectrum and prognostic factors based upon 117 cases

Be sure to sign up for the weekly First Opinion Podcast on Apple Podcasts, Spotify , or wherever you get your podcasts

Thats where targeted supplementation comes in

Cravings start to fade Your body stops constantly asking for more food

Key findings (Vafaei et al., 2025): 30-50 mg/kg mirtazapine: dose-dependent seizure suppression Mediated by CB1/CB2 activation (proven by antagonist blockade) GABA-independent mechanism (distinct from benzodiazepines) Appetite/weight gain provides in-vivo functional validation of CB1 engagement The broader implication: Clinicians and researchers have been using ECS pharmacologyunknowinglyfor decades

Short-acting GLP-1 receptor agonists including exenatide immediate-release (Byetta) should be injected within 60 minutes before morning and evening meals , and lixisenatide (Lyxumia) should be administered within 1 hour before any meal of the day